Lifestyle Drugs and Psychiatric Adverse Events in Randomised Clinical Trials

被引:0
|
作者
Willemen, M. J. [1 ,2 ]
Mantel-Teeuwisse, A. K. [1 ,2 ]
Straus, S. M. [2 ,3 ]
Egberts, A. C. [1 ,4 ]
Leufkens, H. G. [1 ,2 ]
机构
[1] UIPS, Utrecht, Netherlands
[2] MEB, The Hague, Netherlands
[3] Erasmus Univ, Med Ctr, Dept Med Informat, Rotterdam, Netherlands
[4] Univ Med Ctr Utrecht, Dept Clin Pharm, Utrecht, Netherlands
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
424
引用
收藏
页码:S180 / S180
页数:1
相关论文
共 50 条
  • [1] Reporting of Psychiatric Adverse Events in Randomised Clinical Trials
    Willemen, M. J. C.
    Mantel-Teeuwisse, A. K.
    Straus, S. M. J. M.
    Egberts, A. C. G.
    Leufkens, H. G. M.
    [J]. DRUG SAFETY, 2010, 33 (10) : 936 - 936
  • [2] Clinical correlates of psychiatric adverse events of anticonvulsant drugs in patients with epilepsy
    Mula, M.
    Trimble, M. R.
    Sander, J. W.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S535 - S535
  • [4] Psychiatric adverse events during treatment with brodalumab: Analysis of psoriasis clinical trials
    Lebwohl, Mark G.
    Papp, Kim A.
    Marangell, Lauren B.
    Koo, John
    Blauvelt, Andrew
    Gooderham, Melinda
    Wu, Jashin J.
    Rastogi, Shipra
    Harris, Susan
    Pillai, Radhakrishnan
    Israel, Robert J.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (01) : 81 - +
  • [5] Clinical trials on adverse events of therapy
    Alonso, Miguel Araujo
    [J]. MEDWAVE, 2011, 11 (09):
  • [6] Reply to: "Psychiatric adverse events during treatment with brodalumab: Analysis of psoriasis clinical trials''
    Lebwohl, Mark
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (03)
  • [7] Safety of biological drugs in rheumatoid arthritis: An assessment of quality of reporting of adverse events in randomised controlled trials
    Hadi, Muhammad
    McHugh, Gretl
    Conaghan, Philip
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2017, 69 : 5 - 6
  • [8] Reporting of adverse events in randomised controlled trials of antiepileptic drugs using the CONSORT criteria for reporting harms
    Shukralla, Arif A.
    Tudur-Smith, Catrin
    Powell, Graham A.
    Williamson, Paula R.
    Marson, Anthony G.
    [J]. EPILEPSY RESEARCH, 2011, 97 (1-2) : 20 - 29
  • [9] Quality of Methods for Assessing and Reporting Serious Adverse Events in Clinical Trials of Cancer Drugs
    Belknap, S. M.
    Georgopoulos, C. H.
    West, D. P.
    Yarnold, P. R.
    Kelly, W. N.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (02) : 231 - 236
  • [10] Adverse Syndromes and Psychiatric Drugs: A Clinical Guide
    Mace, Shubhra
    [J]. PSYCHIATRIC BULLETIN, 2006, 30 (02): : 79 - 79